Skeletal Myopathy as the Initial Manifestation of Light Chain Multiple Myeloma

Skeletal Myopathy as the Initial Manifestation of Light Chain Multiple Myeloma

Monoclonal gammopathies due to plasma cell dyscrasias can cause various rare neuromuscular disorders. The peripheral nervous system is most commonly affected, while muscle diseases associated with monoclonal gammopathies are rare. Skeletal myopathy, as a manifestation in the context of multiple myel...

Full description

Bibliographic Details
Main Authors:	Mohamed Reda Belkhribchia, Sara Moukhlis, Tarik Bentaoune, Najat Chourkani, Mohamed Zaidani, Mehdi Karkouri
Format:	Article
Language:	English
Published:	SMC MEDIA SRL 2020-11-01
Series:	European Journal of Case Reports in Internal Medicine
Subjects:	light chain deposition disease skeletal myopathy light chain multiple myeloma monoclonal immunoglobulin deposition disease chemotherapy
Online Access:	https://www.ejcrim.com/index.php/EJCRIM/article/view/2095

Similar Items

Acquired cutis laxa associated with light and heavy chain deposition disease
by: Reena A Majithia, et al.
Published: (2018-01-01)

Light-chain deposition disease is a hematologic problem
by: I G Rekhtina, et al.
Published: (2017-01-01)

The concurrence of light-chain deposition disease, AL-amyloidosis, and cast nephropathy in a patient with multiple myeloma
by: I G Rekhtina, et al.
Published: (2015-06-01)

An Unusual Case of Cholestatic Hepatitis due to Light-Chain Deposition Disease
by: Alessandro Grembiale, et al.
Published: (2020-11-01)

Long-term reversibility of renal dysfunction associated to light chain deposition disease with bortezomib and dexamethasone and high dose therapy and autologous stem cell transplantation
by: Tomás J. González-López, et al.
Published: (2011-11-01)

Clinicopathological characteristics of light chain proximal tubulopathy in Korean patients and the diagnostic usefulness of immunohistochemical staining for immunoglobulin light chain
by: Minsun Jung, et al.
Published: (2020-04-01)

Monoclonal Gammopathies of Renal Significance: Renal Biopsy and Beyond
by: Paolo Menè, et al.
Published: (2020-06-01)

Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains
by: Arfa, A., et al.
Published: (2021)

Secondary monoclonal gammopathy after bone marrow autotransplantation as a cause of worse renal function in light chain immunoglobulin deposition disease
by: I G Rekhtina, et al.
Published: (2016-06-01)

Light-Chain Deposition Disease with Prominent Hepatic Involvement
by: Ana Vaz Cristino, et al.
Published: (2017-04-01)

Light‐chain amyloid myopathy isolated to skeletal muscles: A case report
by: Toshihiro Matsukawa, et al.
Published: (2020-12-01)

Multiple Myeloma-Associated Light Chain Amyloidosis and a Proposed Approach to Monoclonal Immunoglobulin-Associated Renal Disease
by: Zi Yun Chang, et al.
Published: (2020-09-01)

Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it?
by: Juana Jiménez Jiménez, et al.
Published: (2015-01-01)

Free light chains of immunoglobulins in the diagnosis and prognosis of multiple myeloma
by: N. V. Lyubimova, et al.
Published: (2017-05-01)

Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
by: Takafumi Tsushima, et al.
Published: (2021-01-01)

Renal monoclonal immunoglobuline deposition disease as a rare variant of renal damage in multiple myeloma
by: Svetlana Vladimirovna Gorchakova, et al.
Published: (2009-07-01)

Pharmacodynamic characteristics of velkeid efficacy in resistant and recurrent multiple myeloma: determination of free light chains of blood serum immunoglobulins
by: Anatoliy Konstantinovich Golenkov, et al.
Published: (2009-07-01)

The experience of free light chains of immunoglobulin elimination in patients with monoclonal gammopathies
by: E. G. Gromova, et al.
Published: (2019-07-01)

Acute Kidney Injury in Monoclonal Gammopathies
by: Paolo Menè, et al.
Published: (2021-08-01)

Nephropathy caused by non-amyloid organized and granular deposits as multiple myeloma syndrome
by: Irina Germanovna Rekhtina, et al.
Published: (2011-07-01)

Comparison of the free and total light chain assays in serum and urine samples with immunofixation electrophoresis for detecting monoclonal proteins in patients with monoclonal gammopathy
by: Korpysz Maciej, et al.
Published: (2014-09-01)

Multiple Myeloma and Renal Failure
by: Patrizia Tosi, et al.
Published: (2015-03-01)

An unusual cause of gross hematuria and renal dysfunction in a young male
by: M Rathi, et al.
Published: (2013-01-01)

Acute kidney injury on chronic kidney disease: from congestive heart failure to light chain deposition disease and cast nephropathy in multiple myeloma
by: Sana Shaikh, et al.
Published: (2019-07-01)

Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
by: Koulieris Efstathios, et al.
Published: (2012-04-01)

Light-Chain Deposition Disease Presenting with Spontaneous Splenic Rupture
by: Luís Pontes dos Santos, et al.
Published: (2018-12-01)

The importance of serum immunoglobulin free light chain assessment for predicting outcome in patients with newly diagnosed multiple myeloma in real clinical practice
by: N. V. Skvortsova, et al.
Published: (2020-10-01)

Clinical profile of Saudi patients with multiple myeloma
by: Alanoud Abdulaziz Alhuqayl, et al.
Published: (2019-01-01)

Is the serum light chain quantification more sensitive than immunofixation in the diagnosis and follow up of patients with multiple myeloma ?
by: Guillermo José Ruiz-Argüelles
Published: (2014-08-01)

Renal tubular P-glycoprotein expression is reduced in plasma cell disorders
by: Cihan Heybeli, et al.
Published: (2019-06-01)

Relationship of differences in immunoglobulin heavy/light chain pairs (HevyliteTM), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma
by: Vlastimil Scudla, et al.
Published: (2016-03-01)

Nodular pulmonary deposition disease in a patient with the acquired immunodeficiency syndrome: a case report
by: Jessica N. Mezzanotte, et al.
Published: (2020-06-01)

Coexistent amyloid fibrils in a patient with combined light chain deposition disease and light chain cast nephropathy
by: Urmila Anandh, et al.
Published: (2019-01-01)

Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy
by: Smita Mary Matthai, et al.
Published: (2020-01-01)

The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease
by: Alícia Molina-Andújar, et al.
Published: (2020-03-01)

Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review
by: Xin Zhang, et al.
Published: (2021-10-01)

ASSESSMENT OF THE RESIDUAL TUMOR IN PATIENTS WITH MULTIPLE MYELOMA BASED ON THE ANALYSIS OF THE FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN BLOOD SERUM
by: T. A. Мitina, et al.
Published: (2016-02-01)

Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease
by: Rebecca Sternke-Hoffmann, et al.
Published: (2020-03-01)

Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment
by: Lidia V. Lysenko (Kozlovskaya), et al.
Published: (2020-07-01)

The pathogenesis of renal injury and treatment in light chain deposition disease
by: Qi Wang, et al.
Published: (2019-11-01)